-       Drug Pipelines 
   - February 2023
    -  127 Pages 
    Global
   
   From       €13456EUR$14,995USD£11,809GBP 
                -       Report 
   - February 2023
    -  32 Pages 
    Global
   
   From       €3585EUR$3,995USD£3,146GBP 
                -       Report 
   - November 2021
    -  131 Pages 
    Global
   
   From       €13456EUR$14,995USD£11,809GBP 
                -       Report 
   - February 2024
    -  128 Pages 
    Global
   
   From       €3500EUR$4,178USD£3,179GBP 
                -       Report 
   - January 2024
    -  93 Pages 
    Global
   
   From       €3500EUR$4,178USD£3,179GBP 
                 -       Report 
   - October 2023
    -  95 Pages 
    Global
   
   From       €3500EUR$4,178USD£3,179GBP 
                -       Report 
   - January 2024
    -  109 Pages 
    Global
   
   From       €3500EUR$4,178USD£3,179GBP 
                  -       Report 
   - March 2024
    -  150 Pages 
    Global
   
   From       €3455EUR$3,850USD£3,032GBP 
      €4352EUR$4,850USD£3,820GBP 
                -       Report 
   - May 2024
    -  100 Pages 
    Africa
   
   From       €1795EUR$2,000USD£1,575GBP 
                -       Report 
   - April 2024
    -  100 Pages 
    Africa
   
   From       €1795EUR$2,000USD£1,575GBP 
                -       Report 
   - April 2024
    -  80 Pages 
    China
   
   From       €1346EUR$1,500USD£1,181GBP 
                -       Report 
   - April 2024
    -  80 Pages 
    France
   
   From       €1346EUR$1,500USD£1,181GBP 
                -       Report 
   - April 2024
    -  80 Pages 
    Germany
   
   From       €1346EUR$1,500USD£1,181GBP 
                -       Report 
   - April 2024
    -  80 Pages 
    India
   
   From       €1346EUR$1,500USD£1,181GBP 
                -       Report 
   - April 2024
    -  80 Pages 
    Saudi Arabia
   
   From       €1346EUR$1,500USD£1,181GBP 
                -       Report 
   - April 2024
    -  80 Pages 
    South Korea
   
   From       €1346EUR$1,500USD£1,181GBP 
                From       €1346EUR$1,500USD£1,181GBP 
                -       Report 
   - April 2024
    -  80 Pages 
    United Kingdom
   
   From       €1346EUR$1,500USD£1,181GBP 
                -       Report 
   - April 2024
    -  80 Pages 
    France
   
   From       €1346EUR$1,500USD£1,181GBP 
                -       Report 
   - April 2024
    -  80 Pages 
    India
   
   From       €1346EUR$1,500USD£1,181GBP 
             
          The Analgesics market is a sector of the pharmaceutical industry that focuses on the production and sale of drugs used to relieve pain. Analgesics are used to treat a variety of conditions, including headaches, muscle pain, arthritis, and post-operative pain. Common analgesics include non-steroidal anti-inflammatory drugs (NSAIDs), opioids, and acetaminophen.
Analgesics are available in a variety of forms, including tablets, capsules, liquids, and topical creams. Many analgesics are available    over-the-counter, while others require a prescription.
The analgesics market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the analgesics market include Pfizer, Johnson & Johnson, GlaxoSmithKline, Novartis, and Merck. Show Less   Read more